Prelude Capital Management, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $137,275 - $321,005	-1,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $200,896 - $285,984	1,600 Added 533.33%	1,900 $324,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $1.16 Million - $2.06 Million	-15,200 Reduced 98.06%	300 $39,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $917,406 - $1.98 Million	12,600 Added 434.48%	15,500 $1.17 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $291,746 - $395,069	2,600 Added 866.67%	2,900 $441,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $21,334 - $30,336	-200 Reduced 40.0%	300 $36,000
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $166,740 - $198,625	-3,500 Reduced 87.5%	500 $28,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $142,920 - $188,600	4,000	4,000 $181,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.